{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T11:45:07Z","timestamp":1771674307108,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T00:00:00Z","timestamp":1514505600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Racial and Ethnic Health Disparities"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s40615-017-0453-y","type":"journal-article","created":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T15:29:52Z","timestamp":1514561392000},"page":"1052-1058","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Assessing Racial Disparities in HCV Infection and Care Outcomes in a Southern Urban Population"],"prefix":"10.1007","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7679-6306","authenticated-orcid":false,"given":"Keanan","family":"McGonigle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tess","family":"Carley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarissa","family":"Hoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,29]]},"reference":[{"key":"453_CR1","unstructured":"World Health Organization. Hepatitis C. World Health Organization 2016. http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en\/ . Accessed 21 Sept 2017."},{"key":"453_CR2","unstructured":"Centers for Disease Control and Prevention. Hepatitis C FAQs for health professionals. 2017. https:\/\/www.cdc.gov\/hepatitis\/hcv\/hcvfaq.htm#section1 . Accessed 21 Sept 2017."},{"key":"453_CR3","unstructured":"Centers for Disease Control and Prevention. Testing recommendations for hepatitis C virus infection. 2015. https:\/\/www.cdc.gov\/hepatitis\/hcv\/guidelinesc.htm Accessed 21 Sept 2017."},{"key":"453_CR4","unstructured":"Franciscus, A. & Heather Lusk. Hepatitis C Support Project (HCSP) fact sheet: HCV diagnostic tools. HCV Advocate. 2013. http:\/\/hcvadvocate.org\/hepatitis\/factsheets_pdf\/antibody_test.pdf . Accessed 21 Sept 2017."},{"issue":"5","key":"453_CR5","doi-asserted-by":"publisher","first-page":"725","DOI":"10.4254\/wjh.v7.i5.725","volume":"7","author":"H Barth","year":"2015","unstructured":"Barth H. Hepatitis C virus: is it time to say goodbye yet? Perspectives and challenges for the next decade. World J Hepatol. 2015;7(5):725\u201337. https:\/\/doi.org\/10.4254\/wjh.v7.i5.725 .","journal-title":"World J Hepatol"},{"key":"453_CR6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M13-1133","volume":"160","author":"Denniston","year":"2014","unstructured":"Denniston, et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med. 2014;160:293\u2013300.","journal-title":"Ann Intern Med"},{"issue":"Suppl 4","key":"453_CR7","doi-asserted-by":"publisher","first-page":"S555","DOI":"10.2105\/AJPH.2014.302090","volume":"104","author":"LI Backus","year":"2014","unstructured":"Backus LI, Belperio PS, Loomis TP, Mole LA. Impact of race\/ethnicity and gender on HCV screening and prevalence among US veterans in Department of Veterans Affairs Care. Am J Public Health. 2014;104(Suppl 4):S555\u201361. https:\/\/doi.org\/10.2105\/AJPH.2014.302090 .","journal-title":"Am J Public Health"},{"issue":"1","key":"453_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1086\/498512","volume":"42","author":"BL Pearlman","year":"2006","unstructured":"Pearlman BL. Hepatitis C virus infection in African Americans. Clinical Infectious Disease. 2006;42(1):82\u201391. https:\/\/doi.org\/10.1086\/498512 .","journal-title":"Clinical Infectious Disease"},{"key":"453_CR9","doi-asserted-by":"crossref","unstructured":"Kuncio D, Hueber A, Viner K, and Newbern C. Factors associated with spontaneous resolution of HCV infection in untreated individuals. ID Week 2014, Philadelphia, Abstract 1147. http:\/\/www.infohep.org\/Age-sex-and-race-predict-spontaneous-hepatitis-C-virus-clearance\/page\/2915305\/","DOI":"10.1093\/ofid\/ofu052.855"},{"issue":"5","key":"453_CR10","doi-asserted-by":"publisher","first-page":"846","DOI":"10.2105\/AJPH.2007.113225","volume":"98","author":"CM Rousseau","year":"2008","unstructured":"Rousseau CM, Ioannou GH, Todd-Stenberg JA, Sloan KL, Larson MF, Forsberg CW, et al. Racial differences in the evaluation and treatment of hepatitis C among veterans: a retrospective cohort study. Am J Public Health. 2008;98(5):846\u201352. https:\/\/doi.org\/10.2105\/AJPH.2007.113225 .","journal-title":"Am J Public Health"},{"issue":"1","key":"453_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jnma.2015.12.004","volume":"108","author":"J Wilder","year":"2016","unstructured":"Wilder J, Saraswathula A, Hasselblad V, Muir A. A systematic review of race and ethnicity in hepatitis C clinical trial enrollment. J Natl Med Assoc. 2016;108(1):24\u20139. https:\/\/doi.org\/10.1016\/j.jnma.2015.12.004 .","journal-title":"J Natl Med Assoc"},{"issue":"1","key":"453_CR12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/hep.22070.","volume":"47","author":"RT Chung","year":"2008","unstructured":"Chung RT, Gale M Jr, Polyak SJ, Lemon SM, Liang TJ, Hoofnagle JH. Mechanisms of action of interferon and ribavirin in chronic hepatitis C: summary of a workshop. Hepatology. 2008;47(1):306\u201320. https:\/\/doi.org\/10.1002\/hep.22070.","journal-title":"Hepatology"},{"issue":"9954","key":"453_CR13","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/S0140-6736(14)61059-X","volume":"384","author":"M Manns","year":"2014","unstructured":"Manns M, Pol S, Jacobson IM, Marcellin P, Gordon SC, Peng CY, et al. All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study. Lancet. 2014;384(9954):1597\u2013605. https:\/\/doi.org\/10.1016\/S0140-6736(14)61059-X .","journal-title":"Lancet"},{"key":"453_CR14","doi-asserted-by":"publisher","unstructured":"Zhang S, Bastian ND, Paul M. Griffin. Cost-effectiveness of sofosbuvir-based treatments for chronic hepatitis C in the US. BMC Gastroenterol. 2015;15(98) https:\/\/doi.org\/10.1186\/s12876-015-0320-4 .","DOI":"10.1186\/s12876-015-0320-4"},{"key":"453_CR15","unstructured":"Louisiana Office of Public Health. Epidemiologic profile of hepatitis C virus infection in Louisiana\u20142015. 2015. http:\/\/new.dhh.louisiana.gov\/assets\/oph\/Center-PHCH\/Center-CH\/infectious-epi\/Hepatitis\/HepC\/HepCEpiProfile.pdf . Accessed 21 Sept 2017."},{"key":"453_CR16","unstructured":"Department of Health & Human Services. National Viral Hepatitis Action Plan 2017\u20132020. 2017. https:\/\/www.hhs.gov\/sites\/default\/files\/National%20Viral%20Hepatitis%20Action%20Plan%202017-2020.pdf . Accessed 21 Sept 2017."},{"issue":"Suppl 1","key":"453_CR17","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/infdis\/jis927","volume":"207","author":"AY Kim","year":"2013","unstructured":"Kim AY, Onofrey S, Church DR. An epidemiologic update on hepatitis C infection in persons living with or at risk of HIV infection. J Infect Dis. 2013 Mar 15;207(Suppl 1):S1\u20136. https:\/\/doi.org\/10.1093\/infdis\/jis927 .","journal-title":"J Infect Dis"}],"container-title":["Journal of Racial and Ethnic Health Disparities"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40615-017-0453-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-017-0453-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-017-0453-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T17:27:48Z","timestamp":1570555668000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40615-017-0453-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,29]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["453"],"URL":"https:\/\/doi.org\/10.1007\/s40615-017-0453-y","relation":{},"ISSN":["2197-3792","2196-8837"],"issn-type":[{"value":"2197-3792","type":"print"},{"value":"2196-8837","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,29]]}}}